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Background: The Scottish Antimicrobial Prescribing Group (SAPG) was established in 2008 to lead delivery of the
national antimicrobial stewardship programme. We performed a national self-reported survey in 2014 to evaluate
stewardship activities delivered by regional Antimicrobial Management Teams (AMTs). An on-line survey was developed
utilising validated indicators from a published European study along with questions specific to the Scottish context.
Descriptive statistics were used to evaluate the responses received.
Findings: The survey was completed by 14 of the 15 AMTs (response rate 93 %). Results demonstrated good
compliance with 9 of the 10 key European indicators included in the survey; 7 (50 %) of AMTs achieved all 9
indicators and 14 (100 %) of AMTs achieved at least 6 out of 9 indicators (67 %). Progress was also demonstrated
across a range of stewardship activities and areas for further work were identified.
Conclusions: The survey results suggest the national stewardship programme in Scotland has reached maturity
but consolidation and ongoing development are required. Collaborative working between SAPG and AMTs
together with central funding has been key to achieving this level of success.
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Antimicrobial resistance is recognised as a major global
threat to healthcare and a post-antibiotic era is a real
possibility [1, 2]. Antimicrobial stewardship programmes
are vital to contain resistance and preserve the efficacy
of the antimicrobial armamentarium particularly for
multi-drug resistant gram negative infections emerging
in the UK and elsewhere [3, 4]. The 2013 UK Antimicrobial
Resistance Strategy places stewardship high in its recom-
mendations [5] and is complemented by the 2014 refresh
of the Scottish Management of Antimicrobial Resistance
Action Plan (ScotMARAP) [6]. Healthcare in Scotland is
delivered via one national National Health Service (NHS)
board providing elective surgery and 14 regional NHS
boards (11 mainland and 3 island boards), which* Correspondence: jacqueline.sneddon@nhs.net
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Scottish Antimicrobial Prescribing Group (SAPG) was
established in 2008 to lead and co-ordinate delivery of
the original ScotMARAP and includes representatives
from all mainland boards. SAPG have supported multi-
professional Antimicrobial Management Teams (AMTs),
one per board as sub-groups of the Drug and Therapeu-
tics Committee, to implement stewardship across primary
and secondary care. These AMTs include, as a minimum,
a lead clinician, a microbiologist and an antimicrobial
pharmacist but most also include an Infection Control
and a primary care representative plus other clinicians.
With the publication of these new strategy documents
[5, 6], SAPG agreed it was timely to review the struc-
ture and function of AMTs, identify ongoing challenges
and compare progress across Scotland. Measurement of
stewardship and the need for common structure and
process indicators for hospital stewardship programmes
was recommended in the recent transatlantic taskforcearticle distributed under the terms of the Creative Commons Attribution License
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[8] developed and validated a series of structure indicators
using a multidisciplinary panel from four European coun-
tries who identified a series of 58 indicators, ranked them
using a scoring system and then agreed the value of each
via a face-to-face consensus meeting. We have used 9 of
Buyle’s 10 key indicators adapted to the Scottish context
along with questions specific to delivery of ScotMARAP
and other SAPG initiatives to evaluate our progress.
Method
A survey was developed utilising a Survey Monkey©
on-line tool with four domains of questions exploring
various aspects of stewardship. The tool was tested by two
boards to identify any practical issues or ambiguity in the
questions. A web link to the survey was then sent via email
to all 15 AMT Lead Clinicians, including those in the
two test boards, who were asked to discuss with AMT
colleagues and submit a response on behalf of the team.
Results
Survey participation An excellent response was ob-
tained with all boards completing the survey except one
small island board serving less than 0.5 % of the Scottish
population.Fig. 1 Performance of 14 Scottish AMTs against 10 European validated IndComparison with European validated indicators Self-
reported performance against these indicators is shown
in Fig. 1. All boards are achieving at least six of the key
European indicators and seven boards (50 %) are achiev-
ing all nine.
Additional indicators across the 4 domains A selection
of the indicators is shown in Fig. 2 and highlights include:
 High levels of ‘excellent’ or ‘good’ collaborative
working with Drug and Therapeutics Committees,
Infection Prevention/Control Teams and Primary
Care Teams. Engagement with Patient Safety Teams
less effective.
 Good engagement with audit activities and surveillance
of antimicrobial use at hospital level in most boards.
Surveillance at ward level was less widespread due to
local computer system capability and staff resource.
 High usage of a variety of stewardship tools to
support safe and appropriate use of antimicrobials.
 A formal education programme on stewardship
available in most boards but training mandatory in only
half of the boards and mostly for Junior Medical Staff.
Only half of boards delivering the primary care
resource aimed at reducing unnecessary antibiotic use.icators
Fig. 2 Performance of 14 Scottish AMTs against 18 other Stewardship Initiatives and Practices
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Charani et al [9] suggested that a whole system approach
is essential to the success of stewardship and our survey
response rate indicates good engagement with stewardship
activities across Scotland. A recognised flaw in our ap-
proach is that responses were self-reported and therefore
not validated. The achievements assessed using validated
structure quality indicators [7] together with specific Scot-
tish measures suggest a mature stewardship programme.
The dedicated central funding [10] provided to support
the SAPG infrastructure and antimicrobial pharmacists in
every board has allowed local AMTs to meet the recom-
mendations within the original ScotMARAP document.
There is, however, no room for complacency and we must
consolidate current success and develop new approaches.
A collaborative and integrated approach to stewardship,
infection prevention and patient safety has been widely
commended [11] and has been a key focus in Scotland to
support the Healthcare Associated Infection agenda. There-
fore, it is reassuring to confirm this joined up approach
together with Drug and Therapeutics Committee links
which ensures local strategic and operational directionand accountability. Each board has its own local anti-
microbial policies which are developed and reviewed by
the AMT and formally approved by the local Drug and
Therapeutics Committee. The relationship with patient
safety teams, involved in improving sepsis care and pre-
venting infection, requires further development as only
3 boards reported ‘excellent’ or ‘good’ collaborative work-
ing and 4 boards reported it to be ‘minimal’. However
early examples of success, within individual hospitals, are
emerging and could be the basis of spread to other areas.
Surveillance of antimicrobial use is a key stewardship
activity and boards are engaged with these activities to
varying levels. Antimicrobial data is available through
national systems; the Prescribing Information System (PIS)
provides data for primary care prescribing at GP Practice
level while the Hospital Medicines Utilisation Database
(HMUD) provides information on antimicrobial use at
hospital level only. Data analysis at ward level is variable
and dependant on individual boards’ information systems
as well as staff resources for data extraction. The proposed
introduction of electronic prescribing across Scotland will
facilitate ward level surveillance.
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carbapenems has been adopted by all boards in combination
with formal authorisation by an infection specialist in many
to support our carbapenem reduction strategy [12].
In 2009 in response to increasing rates of Clostridium
difficile infection (CDI) across Scotland national scrutiny
measures were introduced involving a target for all boards
to reduce CDI rates. To support this target a key priority
has been restriction of antimicrobials most associated with
CDI within local policies [13] and boards were mandated
to collect and feed back clinical audit data to confirm this
restriction in the form of prescribing indicators for
hospital and primary care [14]. To provide assurance
of compliance with restrictive policies this data is also
collated at national level utilising a web-based system
and results are reviewed quarterly by SAPG. In addition to
this mandatory audit of prescribing, a programme of point
prevalence surveys are carried out in acute hospitals in
most boards to evaluate the quality of prescribing and re-
sults are fed back to clinical and managerial groups. Some
boards also report auditing in clinical areas if sub-optimal
prescribing has been identified or if surveillance data high-
lights increased use of restricted antibiotics.
An important but challenging element of stewardship
is minimising harm from antimicrobial therapy both in
terms of reducing resistance and also adverse effects at
individual patient level. Restrictions on the use of anti-
microbials with a high risk of CDI have resulted in in-
creased use of gentamicin with potential for increased
rates of renal toxicity and ototoxicity. Therefore SAPG
commissioned a patient safety initiative including develop-
ment of on-line dosage calculators for both gentamicin
and vancomycin [15]. These are now the principal method
of calculating initial and subsequent doses of these antibi-
otics and a national standardised gentamicin prescribing
and monitoring chart [15] has also been adopted by most
boards to guide safe practice.
No stewardship initiative would be complete without an
educational component. There has been significant invest-
ment in development of national education resources to
support antimicrobial stewardship [16]. These are well uti-
lised by all boards to provide face-to-face and e-learning
and most boards have a formal education programme
which is mandatory for specific staff groups in half of
these boards. To support a national target for reduction of
antibiotic use in primary care an education resource was
launched in 2013 for use within GP practices [17]. Al-
though only half of boards have committed to deliver it
within 2014–15 the remainder plan to do so in 2015–16
and SAPG will commence a formal evaluation in 2015.
Conclusion
A national co-ordinated response led by SAPG and em-
braced by local AMTs has resulted in NHS Scotland beingwell positioned to take forward the challenges laid out in
ScotMARAP2 [6] and the UK AMR strategy [5]. National
engagement has been confirmed by this survey showing
that key validated indicators of antimicrobial stewardship
have been well established. Continued prioritisation and
investment will allow us top consolidate this success and
further utilise national and local data to drive improve-
ment [18]. We believe that the use of pragmatic indicators
commended by TATFAR, that can be locally adapted, are
a valuable means of providing assurance about the func-
tion of stewardship programmes at a national and local
level. We hope our survey data outlines their value and
will support the implementation of these indicators across
other healthcare settings.
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